NCT02616913View on ClinicalTrials.gov

Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2013

Conditions
Cardiovascular Abnormalities
Interventions
OTHER

R,R-monatin

Each subject consumes test article R,R-monatin (150 mg) in one of 3 treatment periods

OTHER

Moxifloxacin

Each subject consumes moxifloxacin (400 mg; positive control) in one of 3 treatment periods

OTHER

Placebo

Each subject consumes placebo in one of 3 treatment periods

Sponsors

Lead Sponsor

Cargill
All Listed Sponsors
collaborator

Ajinomoto Co., Inc.

INDUSTRY

lead

Cargill

INDUSTRY

NCT02616913 - Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects | Biotech Hunter | Biotech Hunter